4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000008
President and CEO sold 45,397 shares at $120.03 ($5,449,002)
- President and CEO acquired 45,397 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kramer Robert President and CEO | 2021-02-08 | Option exercise | +32,397 | $30.86 | $999,771 | 171,607 | D: show line 1 in the form |
| Kramer Robert President and CEO | 2021-02-08 | Sale | −32,397 | $120.03 | $3,888,612 | 139,210 | D: show line 2 in the form |
| Kramer Robert President and CEO | 2021-02-08 | Option exercise | +13,000 | $30.63 | $398,190 | 152,210 | D: show line 3 in the form |
| Kramer Robert President and CEO | 2021-02-08 | Sale | −13,000 | $120.03 | $1,560,390 | 139,210 | D: show line 4 in the form |
| Open-market sales · 45,397 sh · avg $120.03 · $5,449,002 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kramer Robert President and CEO | 2021-02-08 | Option exercise · Employee Stock Options (Right to Buy) | −32,397 | $120.03 | $3,888,612 | 0 | D: show line 5 in the form | |||
| Kramer Robert President and CEO | 2021-02-08 | Option exercise · Employee Stock Options (Right to Buy) | −13,000 | $120.03 | $1,560,390 | 19,638 | D: show line 6 in the form |
Loading xslF345X03/wf-form4_161290942063298.xml…